Nanoscale tech tracks proteins inside living neurons to guide Alzheimer's and Parkinson's drug discovery

Дата публикации: 20-10-2026 01:00:02

A technology developed at The University of Queensland allowing scientists to observe how disease-related proteins behave inside living neurons will be used to advance early drug discovery for neurodegenerative diseases. The NASTIC (Nanoscale Spatiotemporal Indexing Clustering) platform, spun out into Brisbane-based startup Accretion Bio, enables researchers to study real-time biological processes in living cells across space and time at the single-molecule level for the first time.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	A groundbreaking brain map could revolutionize Parkinson’s treatment	8	9	03-11-2025
2	Engineered microglia show promise for treating Alzheimer's and other brain diseases	5	7	21-04-2025
3	Nanoparticles induce neuroregeneration in Alzheimer's disease models	0	6.87	26-08-2026
4	Science & Medicine: Pursuing precision medicine for Alzheimer's disease	0	7.06	12-07-2026
5	Researchers at RGCB in Keralam develop nanopore sensors for early detection of Parkinson’s disease	0	12.98	22-09-2026
6	Single molecule becomes quantum sensor for imaging proteins at nanoscale	0	5.97	28-07-2026
7	В Челябинске создали сенсор для ранней диагностики болезни Паркинсона	5	7	21-07-2026
8	Molecular structures provide roadmap for targeted Parkinson’s disease therapeutics	0	8.52	10-08-2026
9	Scientists just watched Alzheimer’s damage happen in real time	0	8	07-04-2026
10	Molecular switch controls how cells load cargo for recycling	0	4.94	19-10-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 9.88. Источник: phys.org.